低分子原薬市場：タイプ別、製品別、用途別-2024-2030年の世界予測

低分子原薬市場規模は2023年に1,843億2,000万米ドルと推定され、2024年には1,973億5,000万米ドルに達し、CAGR 7.26%で2030年には3,011億9,000万米ドルに達すると予測されます。

低分子医薬品有効成分は、通常900ダルトン以下の低分子量の有機化合物です。これらの分子は医薬品中の活性成分であり、患者に投与された際に意図した治療効果を引き出す役割を担っています。低分子原薬は、その小ささと単純な構造から細胞膜を容易に拡散することができ、細胞内部位を標的とする場合に特に効果的です。がん、心血管疾患、感染症などの慢性疾患の増加は、市場の成長に寄与しています。医薬品開発サイクルの加速と世界のジェネリック医薬品の普及が、低分子原薬の利用を後押ししています。しかし、医薬品開発に関連する高いコストと厳しい規制基準が市場の成長を制限しています。さらに、医薬品有効成分への曝露による健康への影響が市場成長の妨げとなっています。しかし、費用対効果の高い場所への生産のアウトソーシング、洗練された合成方法の開発、創薬におけるAIの活用といった戦略は、チャンスに満ちた業界にとってゲームチェンジャーとなる可能性があります。急成長するジェネリック医薬品の人気と製造受託部門の拡大により、さらなる成長機会が存在します。

タイプ副作用の軽減により、生物学的テーマへの傾向が高まる

生物由来の低分子原薬は生物に由来するか、生物の成分を含んでいます。これらのAPIは通常、組換えDNA技術、制御された遺伝子発現、抗体技術、発酵プロセスなどのバイオテクノロジー的手法によって製造されます。生物学的原薬は、合成原薬と比較して構造が複雑であることが多く、高い特異性や副作用の軽減など、独自の治療上の利点を提供する可能性があります。合成低分子原薬は、様々な化学合成プロセスを通じて化学的に製造されます。この分野は、製造が比較的容易で拡張性があり、医薬品開発における化学合成の歴史が豊富であることから、低分子原薬市場を独占しています。合成原薬は、生物学的原薬に比べて大量かつ低コストで生産することができます。合成原薬はジェネリック医薬品や一般用医薬品を含む幅広い医薬品を包含し、多くの疾患の治療に不可欠です。

生産品質基準を確保するための自社製造の増加

受託製造機関（CMO）は、低分子原薬市場において極めて重要な役割を果たしています。CMOは、コスト削減、社内設備の不足、専門知識の必要性など、様々な理由で製造の外部委託を希望する製薬会社に製造サービスを提供しています。受託製造は、より柔軟な対応が可能であり、規制遵守や品質管理など、低分子原薬の製造に関連する複雑な問題を管理するのに役立ちます。自社製造とは、低分子原薬の製造設備を自社で保有している製薬会社を指します。このセグメントには、原薬の合成から最終製品の製剤化まで、医薬品の製造プロセス全体をサポートできる広範なリソースとインフラを持つ大手製薬会社が含まれます。自社製造により、製造工程をより詳細に管理することが可能となり、製造と研究開発の統合が進む可能性があるほか、知的財産の保護やサプライチェーンマネジメントの面でも戦略的優位性をもたらすことができます。

応用：がん領域における継続的な進歩は、低分子原薬の活用を強化します。

CVDの治療に使用される低分子医薬品には、抗高血圧薬、抗凝固薬、コレステロール低下薬などがあります。これらの原薬の需要は、心臓病、高血圧、脳卒中の世界の有病率の高さによって牽引されており、心血管治療薬の強力なパイプラインが必要とされています。糖尿病関連原薬は、世界の1型糖尿病と2型糖尿病の罹患率の増加により拡大しています。インスリン感作薬、スルホニル尿素薬、SGLT2阻害薬などの低分子医薬品は、血糖値の管理と糖尿病に伴う合併症の予防に不可欠です。免疫疾患には、自己免疫疾患やアレルギーなど、幅広い疾患が含まれます。これらの疾患の治療に用いられる低分子原薬には、免疫抑制剤、抗炎症剤、抗ヒスタミン剤などがあります。腫瘍学は、低分子原薬市場において最も重要で急速に発展している分野の一つです。オンコロジー原薬の需要は、効果的ながん治療に対する緊急のニーズが原動力となっています。低分子化学療法剤、キナーゼ阻害剤、ホルモン療法は、がん治療レジメンで使用される原薬の一つです。

地域別の洞察

アメリカ地域は、強固な製薬産業、高度なヘルスケア・インフラ、研究開発への重点的な取り組みが特徴です。最先端のバイオテクノロジー企業とともに大手製薬会社が存在することが、低分子原薬の高い需要に寄与しています。米国食品医薬品局（FDA）による厳しい規制が高品質の基準を保証しているため、米国地域は原薬製造にとって魅力的な場所となっています。欧州は低分子原薬の主要市場であり、製薬部門が確立されています。欧州諸国は医薬品の技術革新と生産に大きく貢献していることで知られています。欧州医薬品庁（EMA）は原薬の品質と安全性を規制する上で重要な役割を果たしており、高度に規制された市場環境が醸成されています。さらに、欧州の戦略的貿易協定とジェネリック医薬品への強いこだわりが、同地域における低分子原薬の需要を高めています。中東・アフリカ地域では、生活習慣病の罹患率の増加や医療制度の改善に対する政府の取り組みが、市場の成長を刺激する要因となっています。APAC地域は、中国、日本、インドなどの新興国が牽引して、低分子API市場の急速な成長を目の当たりにしています。これらの国々は、生産コストの低下、熟練した労働力、ヘルスケア・インフラへの投資の増加により、API製造の世界の拠点となりつつあります。同地域の人口の多さと慢性疾患の蔓延も、医薬品と原薬の需要増に寄与しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、低分子原薬市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、低分子原薬市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力などを網羅的に評価します。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.低分子原薬市場の市場規模および予測は？

2.低分子原薬市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.低分子原薬市場の技術動向と規制枠組みは？

4.低分子原薬市場における主要ベンダーの市場シェアは？

5.低分子原薬市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 慢性疾患の増加と世界的に増加する高齢者人口
    • 世界中でジェネリック医薬品の需要が増加
  • 抑制要因
    • 低分子原薬に関連する高コスト
  • 機会
    • 医薬品の発見と開発における継続的な進歩
    • 併用療法に関するバイオ医薬品企業との提携
  • 課題
    • 医薬品開発に対する厳格な規制要件
• 市場セグメンテーション分析
  • タイプ：副作用が少ないため、生物学的ベースの低分子原薬への傾向が高まっている
  • 生産：品質基準を確保するために社内製造を増やす
  • アプリケーション：腫瘍学の継続的な進歩により、低分子原薬の利用が強化されます。
• 市場ディスラプション分析
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 価格分析
• 技術分析
• 特許分析
• 貿易分析
• 規制枠組みの分析

第6章 低分子原薬市場：タイプ別

• 生物学的
• 合成

第7章 低分子原薬市場制作者

• 契約製造
• 社内製造

第8章 低分子原薬市場：用途別

• 心臓血管
• 糖尿病
• 免疫疾患
• 腫瘍学

第9章 南北アメリカの低分子原薬市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の低分子原薬市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの低分子原薬市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • グラニュールズ、新たなグリーン小分子API製造施設に2億5,000万米ドルを投資
  • SSTコーポレーションとViwit Pharmaceuticalsが戦略的提携を確立
  • APIはウォータールー大学の科学者と提携し、コロナウイルスに対する広範囲の低分子治療薬を開発中
• 戦略分析と提言

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. SMALL-MOLECULE APIS MARKET RESEARCH PROCESS
• FIGURE 2. SMALL-MOLECULE APIS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. SMALL-MOLECULE APIS MARKET DYNAMICS
• FIGURE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. SMALL-MOLECULE APIS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY BIOLOGICAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY SYNTHETIC, BY REGION, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CONTRACT MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IN-HOUSE MANUFACTURING, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY CARDIOVASCULAR, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY IMMUNOLOGICAL DISORDERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL SMALL-MOLECULE APIS MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 30. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 31. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 32. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 33. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 34. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 35. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 36. AMERICAS SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 37. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 38. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 39. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 40. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 41. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 42. ARGENTINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 43. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 44. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 45. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 46. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 47. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 48. BRAZIL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 49. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 50. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 51. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 52. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 53. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 54. CANADA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 55. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 56. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 57. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 58. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 59. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 60. MEXICO SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 61. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 62. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 63. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 64. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 65. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 66. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 67. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 68. UNITED STATES SMALL-MOLECULE APIS MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 70. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 72. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 73. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 74. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 75. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 76. ASIA-PACIFIC SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 77. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 78. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 79. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 80. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 81. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 82. AUSTRALIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 83. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 84. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 85. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 86. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 87. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 88. CHINA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 89. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 90. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 91. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 92. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 93. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 94. INDIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 95. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 96. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 97. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 98. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 99. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 100. INDONESIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 101. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 102. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 103. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 104. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 105. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 106. JAPAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 107. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 108. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 109. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 110. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 111. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 112. MALAYSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 113. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 114. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 115. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 116. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 117. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. PHILIPPINES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 120. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 121. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 122. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 123. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 124. SINGAPORE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 126. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 127. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 128. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 129. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 130. SOUTH KOREA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 131. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 132. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 133. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 134. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 135. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 136. TAIWAN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 137. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 138. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 139. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 140. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 141. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 142. THAILAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 143. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 144. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 145. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 146. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 147. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 148. VIETNAM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 152. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 153. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 154. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 155. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 156. EUROPE, MIDDLE EAST & AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 157. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 158. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 159. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 160. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 161. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. DENMARK SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 164. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 165. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 166. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 167. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 168. EGYPT SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 169. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 170. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 171. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 172. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 173. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 174. FINLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 175. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 176. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 177. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 178. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 179. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 180. FRANCE SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 181. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 182. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 183. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 184. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 185. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 186. GERMANY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 187. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 188. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 189. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 190. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 191. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. ISRAEL SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 194. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 195. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 196. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 197. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 198. ITALY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 199. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 200. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 201. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 202. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 203. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 204. NETHERLANDS SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 205. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 206. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 207. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 208. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 209. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 210. NIGERIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 211. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 212. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 213. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 214. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 215. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 216. NORWAY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 217. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 218. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 219. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 220. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 221. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. POLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 224. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 225. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 226. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 227. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 228. QATAR SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 229. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 230. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 231. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 232. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 233. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 234. RUSSIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 236. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 237. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 238. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 239. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 240. SAUDI ARABIA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 242. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 243. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 244. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 245. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 246. SOUTH AFRICA SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 247. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 248. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 249. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 250. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 251. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. SPAIN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 254. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 255. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 256. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 257. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 258. SWEDEN SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 259. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 260. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 261. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 262. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 263. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 264. SWITZERLAND SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 265. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 266. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 267. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 268. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 269. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 270. TURKEY SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 272. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 273. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 274. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 275. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 276. UNITED ARAB EMIRATES SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
• TABLE 278. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
• TABLE 279. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2018-2023 (USD MILLION)
• TABLE 280. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY PRODUCTION, 2024-2030 (USD MILLION)
• TABLE 281. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 282. UNITED KINGDOM SMALL-MOLECULE APIS MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 283. SMALL-MOLECULE APIS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 284. SMALL-MOLECULE APIS MARKET, FPNV POSITIONING MATRIX, 2023

[185 Pages Report] The Small-Molecule APIs Market size was estimated at USD 184.32 billion in 2023 and expected to reach USD 197.35 billion in 2024, at a CAGR 7.26% to reach USD 301.19 billion by 2030.

Small-molecule Active Pharmaceutical Ingredients are organic compounds with a low molecular weight, typically below 900 daltons. These molecules are the active components in pharmaceuticals that are responsible for eliciting the intended therapeutic effect when administered to patients. Small-molecule APIs can easily diffuse across cell membranes because of their small size and simple structure, making them particularly effective in targeting intracellular sites. Growing chronic disease prevalence, including cancer, cardiovascular, and infectious diseases, contributes to the market growth. Accelerated drug development cycles and rising adoption of generic drugs across the globe boost the utilization of small-molecule API. However, high costs and stringent regulatory standards associated with drug development limit the growth of the market. In addition, the health effects of exposure to active pharmaceutical ingredients create hindrances to market growth. However, strategies such as outsourcing production to cost-effective locations, developing sophisticated synthesis methods, and leveraging AI in drug discovery can be potential game-changers for an industry ripe with opportunity. Further growth opportunities exist due to the burgeoning generic drugs popularity and expanding contract manufacturing sectors.

Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects

Biological small-molecule APIs are derived from living organisms or contain components of living organisms. These APIs are typically produced through biotechnological methods, including recombinant DNA technology, controlled gene expression, antibody technologies, and fermentation processes. Biological APIs are often more complex in structure compared to their synthetic counterparts and may offer unique therapeutic benefits, such as high specificity and reduced side effects. Synthetic small-molecule APIs are chemically manufactured through various chemical synthesis processes. This segment dominates the small-molecule APIs market due to the relative ease of production, scalability, and the extensive history of chemical synthesis in drug development. Synthetic APIs can be produced in large quantities and at a lower cost compared to biological APIs. They encompass a wide range of drugs, including generics and over-the-counter medications, and are critical in treating a multitude of conditions.

Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards

Contract manufacturing organizations (CMOs) play a pivotal role in the small-molecule APIs market. They offer their manufacturing services to pharmaceutical companies that prefer to outsource production for various reasons, such as cost reduction, lack of in-house facilities, or the need for specialized expertise. Contract manufacturing allows for greater flexibility and can help companies manage the complexities associated with the production of small-molecule APIs, including regulatory compliance and quality control. In-house manufacturing refers to pharmaceutical companies that maintain their own production facilities for small-molecule APIs. This segment includes large pharmaceutical companies with extensive resources and infrastructure that can support the entire drug manufacturing process, from API synthesis to final product formulation. In-house manufacturing allows for greater control over the production process, potentially leading to better integration of manufacturing and R&D efforts, and can provide a strategic advantage in terms of protecting intellectual property and supply chain management.

Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs

Small-molecule drugs used in the treatment of CVDs include antihypertensives, anticoagulants, and cholesterol-lowering drugs, among others. The demand for these APIs is driven by the high global prevalence of heart disease, hypertension, and stroke, necessitating a robust pipeline of cardiovascular medications. Diabetes-related APIs are expanding due to the increasing incidence of Type 1 and Type 2 diabetes worldwide. Small-molecule drugs such as insulin sensitizers, sulfonylureas, and SGLT2 inhibitors are essential in managing blood glucose levels and preventing complications associated with diabetes. Immunological disorders encompass a wide range of conditions, including autoimmune diseases and allergies. Small-molecule APIs used in the treatment of these disorders include immunosuppressants, anti-inflammatory drugs, and antihistamines. Oncology is one of the most critical and rapidly evolving segments in the small-molecule APIs market. The demand for oncology APIs is driven by the urgent need for effective cancer treatments. Small-molecule chemotherapeutic agents, kinase inhibitors, and hormone therapies are among the APIs used in cancer treatment regimens.

Regional Insights

The American region is characterized by a robust pharmaceutical industry, advanced healthcare infrastructure, and a strong focus on research and development. The presence of major pharmaceutical companies, along with cutting-edge biotechnology firms, contributes to the high demand for small-molecule APIs. Stringent regulations by the U.S. Food and Drug Administration (FDA) ensure high-quality standards, making American regions an attractive location for API manufacturing. Europe stands as a key market for small-molecule APIs, with a well-established pharmaceutical sector. European countries are known for their significant contributions to pharmaceutical innovation and production. The European Medicines Agency (EMA) plays a crucial role in regulating API quality and safety, fostering a highly regulated market environment. Additionally, Europe's strategic trade agreements and a strong emphasis on generic drugs bolster the demand for small-molecule APIs in the region. The increasing incidence of lifestyle-related diseases and government initiatives to improve healthcare systems are factors that could stimulate market growth across the Middle East and Africa. The APAC region is witnessing rapid growth in the small-molecule API market, driven by emerging economies such as China, Japan, and India. These countries are becoming global hubs for API manufacturing due to lower production costs, skilled labor, and increasing investments in healthcare infrastructure. The region's large population base and growing prevalence of chronic diseases also contribute to the rising demand for pharmaceuticals and APIs.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Small-Molecule APIs Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Small-Molecule APIs Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Small-Molecule APIs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Agilent Technologies, Inc., Alacrita Holdings Limited, Albemarle Corporation, Aspen Group, Astrazeneca PLC, Aurobindo Pharma Limited, Bachem Holding AG, Bio-Rad Laboratories, Inc., Boehringer Ingelheim GmbH, Bristol-Myers Squibb, Cambrex Corporation by Permira funds, Carlyle Group, Charles River Laboratories International, Inc., Deciphera Pharmaceuticals, Inc., Dr. Reddy's Laboratories Ltd., F. Hoffmann-La Roche Ltd,, Gilead Sciences, Inc, GlaxoSmithKline PLC, Koninklijke DSM N.V., Lonza Group AG, Merck KGaA, Pfizer, Inc., and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Small-Molecule APIs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
  • Biological
  • Synthetic

• Production
  • Contract Manufacturing
  • In-House Manufacturing

• Application
  • Cardiovascular
  • Diabetes
  • Immunological Disorders
  • Oncology

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Small-Molecule APIs Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Small-Molecule APIs Market?

3. What are the technology trends and regulatory frameworks in the Small-Molecule APIs Market?

4. What is the market share of the leading vendors in the Small-Molecule APIs Market?

5. Which modes and strategic moves are suitable for entering the Small-Molecule APIs Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of chronic diseases coupled with increasing geriatric population globally
    • 5.1.1.2. Rising demand for generic drugs worldwide
  • 5.1.2. Restraints
    • 5.1.2.1. High cost associated with small-molecule APIs
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in drug discovery and development
    • 5.1.3.2. Collaborations with bio-pharmaceutical companies for combination therapies
  • 5.1.4. Challenges
    • 5.1.4.1. Stringent regulatory requirements for drug development
• 5.2. Market Segmentation Analysis
  • 5.2.1. Type: Growing inclination towards biological based small-molecule APIs due to its reduced side effects
  • 5.2.2. Production: Increasing in-house small-molecule APIs manufacturing to ensure quality standards
  • 5.2.3. Application: Ongoing advancements in oncology enhances the utilization of small-molecule APIs
• 5.3. Market Disruption Analysis
• 5.4. Porter's Five Forces Analysis
  • 5.4.1. Threat of New Entrants
  • 5.4.2. Threat of Substitutes
  • 5.4.3. Bargaining Power of Customers
  • 5.4.4. Bargaining Power of Suppliers
  • 5.4.5. Industry Rivalry
• 5.5. Value Chain & Critical Path Analysis
• 5.6. Pricing Analysis
• 5.7. Technology Analysis
• 5.8. Patent Analysis
• 5.9. Trade Analysis
• 5.10. Regulatory Framework Analysis

6. Small-Molecule APIs Market, by Type

• 6.1. Introduction
• 6.2. Biological
• 6.3. Synthetic

7. Small-Molecule APIs Market, by Production

• 7.1. Introduction
• 7.2. Contract Manufacturing
• 7.3. In-House Manufacturing

8. Small-Molecule APIs Market, by Application

• 8.1. Introduction
• 8.2. Cardiovascular
• 8.3. Diabetes
• 8.4. Immunological Disorders
• 8.5. Oncology

9. Americas Small-Molecule APIs Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Small-Molecule APIs Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Small-Molecule APIs Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Granules Investing USD 250 Million for New Green Small-Molecule API Mfg Facility
  • 12.3.2. SST Corporation and Viwit Pharmaceuticals Establish Strategic Collaboration
  • 12.3.3. API partners with the University of Waterloo scientists to develop broad-spectrum small molecule therapeutics against coronaviruses
• 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio